Education
About Us
Working with TipRanks
Follow Us
Enorama Pharma AB (SE:ERMA)
:ERMA
ERMA Stock Chart & Stats
kr2.02
-kr0.30(-12.50%)
At close: 4:00 PM EST
kr2.02
-kr0.30(-12.50%)
Day’s Range― - ―
52-Week Rangekr1.52 - kr3.80
Previous CloseN/A
Volume29.79K
Average Volume (3M)4.35K
Market Cap
kr150.67M
Enterprise Valuekr179.91M
Total Cash (Recent Filing)kr6.56M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.66
Next Earnings
Feb 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding74,588,684
10 Day Avg. Volume2,975
30 Day Avg. Volume4,348
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)22.84
Price to Sales (P/S)11.30
P/FCF Ratio-4.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ERMA FAQ
What was Enorama Pharma AB’s price range in the past 12 months?
Enorama Pharma AB lowest stock price was kr1.51 and its highest was kr3.80 in the past 12 months.
What is Enorama Pharma AB’s market cap?
Enorama Pharma AB’s market cap is kr150.67M.
When is Enorama Pharma AB’s upcoming earnings report date?
Enorama Pharma AB’s upcoming earnings report date is Feb 18, 2026 which is in 64 days.
How were Enorama Pharma AB’s earnings last quarter?
Enorama Pharma AB released its earnings results on Nov 19, 2025. The company reported -kr0.179 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.179.
Is Enorama Pharma AB overvalued?
According to Wall Street analysts Enorama Pharma AB’s price is currently Overvalued.
Does Enorama Pharma AB pay dividends?
Enorama Pharma AB does not currently pay dividends.
What is Enorama Pharma AB’s EPS estimate?
Enorama Pharma AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enorama Pharma AB have?
Enorama Pharma AB has 74,588,684 shares outstanding.
What happened to Enorama Pharma AB’s price movement after its last earnings report?
Enorama Pharma AB reported an EPS of -kr0.179 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.812%.
Which hedge fund is a major shareholder of Enorama Pharma AB?
Currently, no hedge funds are holding shares in SE:ERMA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Enorama Pharma AB
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. It offers nicotine chewing gum for smoking cessation and medical cannabis chewing gums for non-pharma applications, as well as for other applications, such as oromucosal drug delivery and allergic rhinitis. The company is based in Malmö, Sweden.
Technical Analysis
AlzeCure Pharma AB
―
Vivesto AB
―
Klaria Pharma Holding AB
―
Nanexa AB
―
Enzymatica AB
―